A Multicenter Study Evaluating the Discontinuation of Eculizumab Therapy in Children with Atypical Hemolytic Uremic Syndrome

• Автори: Saeed AlZabali (Автор), Sawsan AlBatati (Автор), Khawla Rahim (Автор), Hassan Faqeehi (Автор), Abubaker Osman (Автор), Abdulaziz Bamhraz (Автор), Mohammed A. Saleh (Автор), Jameela A. Kari (Автор), Majed Aloufi (Автор), Loai Eid (Автор), Haydar Nasser (Автор), Abubakr Imam (Автор), Entesar AlHammadi (Автор), Omar Alkandari (Автор), Mohammed Al Riyami (Автор), Sidharth Sethi (Автор), Christoph Licht (Автор), Khalid A. Alhasan (Автор), Abdulkarim AlAnazi (Автор)
• Формат: Книга
• Опубліковано: MDPI AG, 2022-11-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Background: Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening thrombotic microangiopathy (TMA), which has been treated successfully with eculizumab. The optimal duration of eculizumab in treating patients with aHUS remains poorly defined. Methods: We conducted a multicenter retro...